Keshari Lab

Harnessing cancer metabolism and metabolic aberrations @sloan_kettering to develop new imaging and therapeutic strategies. Opinions are our own.

[Keshari Lab @KeshariLab]

#CancerEngineering is a new direction for cancer research, harnessing new technologies engineering techniques to solve fundamental problems in biology and to better understand, diagnose, and treat cancer @GSKGradSchool @MSKCancerCenter

https://t.co/EACG1UQZCt

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/6uaHumnRzk
#aacrRLT27 @KeshariLab

[Keshari Lab @KeshariLab]

This work started when Andrew Cho joined the lab, asking if we could leverage arginine metabolism for in vivo metabolic tracing, building some really interesting findings. Stay tuned for where ornithine goes next…

[Keshari Lab @KeshariLab]

Congrats to @Nancy_T_S for pulling together and leading this great collaborative effort between our lab and @JustinPerryPhD! Here we build more on the concept of metabolic symbiosis… https://t.co/4EF07agQ0H

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/Q56mL3kGPA
#aacrRLT26 @KeshariLab

[Keshari Lab @KeshariLab]

@HsiehLab @pushpa_itagi @fredhutch @Nature Congrats Andrew and coworkers!

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/T2oLS5kJ1g
#aacrRLT26 @KeshariLab

[Kentsis Research Group @KentsisResearch]

Read our latest: Recurrent non-canonical proteoforms in acute myeloid leukemia identified by integrative proteogenomics https://t.co/V9b6lAZHP8

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/5EHcQBhBwt
#aacrRLT26 @juliesut8

[Keshari Lab @KeshariLab]

@KentsisResearch @TwistBioscience @airdlab @davidrliu @KharasLab Interesting twist

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/K77qg1vIDE
#aacrRLT26 @KeshariLab

[Keshari Lab @KeshariLab]

Congrats to Briana for defending her PhD, so many amazing directions all coming together! Especially being able to bridge @KeshariLab and @KharasLab. We are looking forward to the things you do next.

[Keshari Lab @KeshariLab]

@KarunaMDPhD @KharasLab @Nature Congrats Karuna and team!

[AACR @AACR]

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
https://t.co/TpDjm5mIk6
#aacrRLT26 @KeshariLab

[Keshari Lab @KeshariLab]

We are looking for a motivated Post-doctoral scholar to really push the envelope in metabolic imaging. Come join our group at MSK!

https://t.co/I2pH7NqAiM

[Keshari Lab @KeshariLab]

@MarcusDGon Interesting work Marcus, we should follow up more on this

[Keshari Lab @KeshariLab]

For our friends at #SNMMI check out our upcoming @AACR sponsored special conference in January 2027 https://t.co/8NBlpkyHcH

[Keshari Lab @KeshariLab]

@JustinPerryPhD @KentsisResearch 100%

[Keshari Lab @KeshariLab]

@KentsisResearch @ShilatifardLab Very interesting findings!

[Keshari Lab @KeshariLab]

https://t.co/suLIWHA8nO

[Keshari Lab @KeshariLab]

Sensing and Computing is getting a quantum turbo charge, exciting things to come!

https://t.co/xXkwCeMEdE